Intrinsiqq
Sibannac Inc. logo

Sibannac Inc. Financials

SNNC

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 7 available years
Income Statement
TTM
AUG 2016
~1.4:1 split
AUG 2015
~2.5:1 split
AUG 2014
AUG 2013
AUG 2012
Revenues
Revenue-$0$0$0$0$0$0
Cost of Revenue-$0$0$0$0$0$0
Gross Profit-$0$0$0$0$0$0
Operating Expenses
Selling & Marketing–$0$0$0$0$0
General & Administrative–$0$0$0$0$0
Total Operating Expenses-$0$0$2$0$0$0
Operating Income-$0-$0-$2-$0-$0-$0
Non-Operating
Net Interest Expense-$0-$0$0–-$0-$0
Other Non-Operating Income (Expense)–-$0$0–––
Income Tax Expense$0$0$0$0––
Earnings from Continuing Ops–-$0-$0–––
Net Income
Net Income-$0-$0-$2-$0-$0-$0
Per Share Data
Revenue Per Share-$0.01$0.00$0.00$0.00$0.04$0.06
EPS (Basic)-$0.02-$0.02-$0.20-$0.06-$0.03-$0.05
EPS (Diluted)-$0.02-$0.02-$0.20-$0.06-$0.03-$0.05
Weighted Avg Shares (Basic)17.5M17.5M12.1M4.9M5.0M5.0M
Weighted Avg Shares (Diluted)17.5M17.5M12.1M4.9M5.0M–
Shares Outstanding17.5M17.5M12.1M4.9M5.0M5.0M

Sibannac (SNNC) financials: revenue, profit and margins

Sibannac (SNNC) generated about -$213,447.00 in revenue and -$263,756.00 in net income (a 123.6% net margin) over the trailing twelve months, growing at roughly -56.1% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is Sibannac's (SNNC) revenue?+

Sibannac generated about -$213,447.00 in revenue over the trailing twelve months. Revenue has grown at roughly -56.1% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Sibannac profitable?+

Sibannac reported about -$263,756.00 in net loss over the trailing twelve months, a net margin of roughly 123.6%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Sibannac's profit margins?+

Sibannac runs a gross margin of about 29.2%, an operating margin of about 50.1%, a net margin of about 123.6%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Sibannac growing?+

Sibannac's revenue has compounded at roughly -56.1% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside SNNC's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 11 Dec 2017, covering the period ending 28 Feb 2017, as reported to the SEC. Data last refreshed 25 Sept 2026. How this is calculated.

Fiscal year ends Aug.

Peers

Pharmaceutical Preparations · Pick stocks to compare with SNNC

CompareIntrinsic value
PLPLPlandai Biotechnology Inc.
$0.00+0.00%30
FOLDAmicus Therapeutics, Inc.
No recent price45
DAWNDay One Biopharmaceuticals, Inc.
No recent price10
CELUCelularity Inc.
$0.46-1.88%0
AYTUAytu BioPharma Inc.
$2.66+0.00%34
MNKDMannKind Corporation
$3.85-2.53%30
BMRNBiomarin Pharmaceutical Inc.
$60.41-1.64%45
BFRIBiofrontera Inc.
$0.53-7.02%30

Spot a number that looks wrong? Check it in SNNC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing SNNC

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.